Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (8) , 1209-1230
- https://doi.org/10.1016/s0149-2918(01)80102-8
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events TrialCirculation, 1998
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries studyJAMA, 1995
- Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1995
- Cholesterol biosynthesis and metabolismCardiovascular Drugs and Therapy, 1992
- Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)JAMA, 1986
- Epidemiology of coronary heart disease: The Framingham studyThe American Journal of Medicine, 1984
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971